Medical Devices Startups

Fundació Villavecchia is a foundation that supports research, specialized training for medical professionals, and hospital improvements in the fight against childhood cancer. The organization funds research registries, awards fellowships and scholarships for pediatric oncology and hematology specialists, and collaborates with hospital centers to improve patient and family experiences.

1 investor

Unoentrecienmil is a Spanish research foundation that funds investigative projects focused on finding a cure for childhood leukemia through annual research grants.

1 investor

Fundamental XR builds immersive extended-reality (XR) training and simulation solutions for skills development and knowledge acquisition in the medical and MedTech sector, serving clinical, manufacturing, and commercial teams. Its platform includes realistic anatomy simulations, imaging technologies, collaborative training, and an analytics platform, deployable across immersive, app, and web media.

1 investor

Fusion Genomics' ONETest platform integrates targeted metagenomic sequencing with artificial intelligence-driven analysis to identify microbial pathogens from clinical specimens, serving hospital laboratories and critical-care teams for complex infection diagnosis.

1 investor

Fusion Antibodies optimizes antibody development for research and therapeutic applications. The company serves pharmaceutical and biotech customers seeking to enhance antibody performance.

1 investor

Futura is a digital dental laboratory solution that provides dentists with an intraoral scanner, clinical management portal, and lab services with training and support. It serves dental practices seeking to digitize their operations and improve patient care efficiency.

1 investor

Chinese medical device company, founded in 2015, that develops intelligent orthopedic surgical robots along with related medical imaging and medical AI technology. Its systems serve orthopedic surgery, combining surgical navigation with automated execution for hospitals and surgeons.

1 investor

Fuzionaire Theranostics develops radiopharmaceuticals for oncology using its HetSiFA silicon (SiFA) chemistry platform, creating chemically matched fluorine-18 PET diagnostic and radioligand therapy pairs. Its lead program, FTX-426, targets GRPR-expressing solid tumors such as prostate and breast cancer.

1 investor

Fyodor Biosciences develops innovative diagnostics, medicines, and healthcare solutions with a focus on accessible global health. The company is led by scientists and health leaders with expertise in biomedical research and biotechnology.

1 investor

FYR develops a platform to analyze extracellular vesicles from blood samples and generate multiomics insights for disease understanding and personalized treatment selection. The company serves biomedical researchers, drug developers, and clinical diagnostics organizations.

1 investor

Fziomed develops proprietary dual-polymer gel technology for use across multiple surgical applications. The company focuses on providing innovative solutions for surgical procedures.

1 investor

G2GBIO (Good to the Globe Biotech) is a pharmaceutical company developing improved new drug injectable formulations, with platform technology applicable to treatments for various diseases and mass-production techniques. It focuses on supplying medicines under a "Humanity First" vision.

1 investor

Gabar (Gabarx) is a biopharmaceutical company developing small-molecule drug candidates for central nervous system disorders such as anxiety and depression, drawing on deuterium-modified molecule chemistry. Its work spans clinical development, regulatory strategy, and CMC/quality across multiple therapeutic indications.

1 investor

Galenica distributes Leica confocal microscopes for biomedical research, enabling high-precision imaging of subcellular structures and dynamic cellular processes at nanoscopic resolution.

1 investor

Galenvs is a contract research organization offering design, development, testing, and bio-manufacturing services for healthcare and industrial customers. The company applies multidisciplinary technologies and data-driven approaches to enzyme engineering, carbon capture, and therapeutic development.

1 investor

Galvanize Therapeutics develops surgical ablation technology using its proprietary Aliya Pulsed Electric Field (PEF) energy to destroy soft tissue cells through regulated cell death mechanisms. Its products serve clinical fields such as interventional pulmonology and thoracic surgery.

1 investor

Gamida Cell develops cell therapy treatments designed to expand and enhance cells for therapeutic applications. The company focuses on delivering potentially curative therapies to patients with unmet medical needs.

1 investor

Gamma Diagnostics develops diagnostic tests based on Gamma Prime Fibrinogen (GPF), a blood biomarker for assessing inflammation and predicting cardiovascular and infectious disease outcomes. The company serves clinicians and healthcare providers seeking improved patient risk stratification and treatment planning.

1 investor

GammaTile is an FDA-cleared, bioresorbable collagen tile embedded with radiation sources that is implanted during brain tumor removal surgery to deliver targeted radiation to remaining cancer cells. It is indicated for patients with operable, newly diagnosed and recurrent brain tumors such as glioblastoma, brain metastases, and meningiomas.

1 investor

Gan & Lee appears to be a company with significant revenue (4.052 billion reported) and R&D investment activity (1.341 billion CNY), but the page visited does not contain clear information about its core business operations, products, or market focus.

1 investor

Garland Surgical develops the TriActiv Hip (formerly MaltaHip), a total hip replacement implant using a patented tri-axial design intended to improve mobility, stability, and durability while reducing revision surgeries. Aimed at orthopaedic surgeons and hip arthroplasty patients, the company plans to commercialize the device through OEM licensing, with an initial US market entry via FDA 510(k).

1 investor

Gasgon Medical develops fluid management devices for the clinical market, including AirVault, a single-use device that removes air bubbles from IV fluids. The company builds tools to improve IV infusion for patients and clinicians in healthcare settings.

1 investor

Gastrocare Partners operates a network of gastrointestinal practices in the western United States, bringing together established clinical practices to enable collaborative care and advanced interventional endoscopic treatments.

1 investor

Gastro Health is a medical group of board-certified physicians and advanced practitioners specializing in gastrointestinal disorders, nutrition, and digestive health. The group provides comprehensive care including evaluation, treatment, surgery, colorectal procedures, infusion services, diagnostic studies, nutrition therapy, and weight loss programs.

1 investor